IMMUNOGENE ZUSAMMENSETZUNG

Patent europeic · EP2903638 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2903638
Numer da la dumonda
EP13792601
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-10-2013
Publitgà
12-08-2015
Concedì
18-12-2019
Stritgà
09-04-2025
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
A61K 39/09 (2006.01)
Prioritad
US 201261744880 P 03.10.2012
US 201361799123 P 15.03.2013
Dumonda PCT
PCT/EP2013/070656 03.10.2013
Publicaziun PCT
WO2014/053612 10.04.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-04-2025

    Cancellation date

    Cancellation date
    31.10.2020 → 09.04.2025
    Cause for cancellation
    Non-payment of renewal fee → Opposition

    Published in Swissreg on 09.04.2025

  2. 26-02-2025

    Midada

    Published in Swissreg on 26.02.2025

  3. 28-06-2023

    Midada

    Published in Swissreg on 28.06.2023

  4. 19-05-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.05.2021

  5. 18-12-2019

    Concedì

    Published in Swissreg on 18.12.2019

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Inventur

MAIONE, Domenico

I-53100 Siena, IT

GRANDI, Guido

I-53100 Siena, IT

MARGARIT Y ROS, Immaculada

I-53100 Siena, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.